Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Castro

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Trials|April 22, 2024
Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trialBénédicte Dupas, Daniela Castro-Farias, Jean-François Girmens, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Translating potential into practice: the evolving landscape of neural stem cell therapeutics in clinical applicationsShreya Singh Beniwal, Akash Rawat, Neetika Sharma, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Veterinary Microbiology|April 17, 2026
bla<sub>NDM-5</sub>-positive and mcr-9-carrying Escherichia coli lineages in wild Andean condors feeding at landfills in South AmericaDanny Fuentes-Castillo, Víctor Escobar-Gimpel, Bruna Fuga, et al.
Nutrients|June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic TherapyHedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Trials|April 22, 2024
Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trialBénédicte Dupas, Daniela Castro-Farias, Jean-François Girmens, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Translating potential into practice: the evolving landscape of neural stem cell therapeutics in clinical applicationsShreya Singh Beniwal, Akash Rawat, Neetika Sharma, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Veterinary Microbiology|April 17, 2026
bla<sub>NDM-5</sub>-positive and mcr-9-carrying Escherichia coli lineages in wild Andean condors feeding at landfills in South AmericaDanny Fuentes-Castillo, Víctor Escobar-Gimpel, Bruna Fuga, et al.
Nutrients|June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic TherapyHedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Nature Medicine|June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trialHedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Pageof 6